HAYA Therapeutics

Drug Discovery · Molecular Diagnostics
37 daysTime to fillmedian of 6 closed roles
Data updated Nov 20, 2026Full reportReport a mistake

Facts

as of Nov 20, 2026

We are leveraging the power of the dark genome to develop precise and potent RNA therapies for disease driving cell-state reprogramming.

Employees
25US Form 5500 (plan participants) · Dec 2025
Website
hayatx.com
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

People

37 daysTime to fill
25EmployeesUS Form 5500 (plan participants) · Dec 2025
Where the openings areshare of open roles
Science & Research40%▼
Product20%▼
Administrative20%▲
Engineering20%▼

Products

Products →

HAYA Therapeutics has 1 clinical trials on record, 1 under way.

top 6%Web presenceof 133.2M domains by links, Common Crawl
Clinical trials
Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
phase 1 · under way · 10 participants · Nonobstructive Hypertrophic Cardiomyopathy
Oct 2026
Tech stack18
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.
Sources: the outlets named on each headline, each story once

What the registers and the postings say about this employer.

Sanctions lists
OFAC SDN, EU consolidated · sanctionssearch.ofac.treas.gov ↗
No match
Phishing reports
OpenPhish, Phishing.Database · openphish.com ↗
None
Layoff notices
US WARN notices on file · dol.gov ↗
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Footprint

Hiring in 0 cities in 0 countries.

0Cities
0Countries
SiteTypeOpen rolesHires most forEngineering
Source: office addresses in postings and company registers